The obstetric face and challenge of HIV/AIDS

Clinical Obstetrics and Gynecology

Volumn 52, Issue 2, 2009, Pages 270-284

  Guidozzi, Franco ^a,b   Black, Vivian ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antiretroviral treatment; Breast feeding; Developing world; HIV; Pregnancy; Preventing mother to child transmission

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ERGOT ALKALOID; INDINAVIR; ISONIAZID; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; MEFLOQUINE; MISOPROSTOL; NELFINAVIR; NEVIRAPINE; OXYTOCIN; PROSTAGLANDIN F2 ALPHA; PROTEINASE INHIBITOR; PYRIDOXINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; AFRICA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST FEEDING; BRONCHOPNEUMONIA; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSCIOUSNESS; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG BIOAVAILABILITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERVENTILATION; HYPOTENSION; INFANCY; INFANT; INFECTION RISK; INSULIN RESISTANCE; LACTIC ACIDOSIS; LETHARGY; LIVER TOXICITY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALARIA; MATERNAL MORTALITY; MENINGITIS; NAUSEA; NEURAL TUBE DEFECT; NEUTROPENIA; OBSTETRIC CARE; PANDEMIC; PATIENT COUNSELING; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PROGNOSIS; SEROLOGY; SEROPREVALENCE; SIDE EFFECT; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; STRATEGIC PLANNING; TACHYPNEA; TERATOGENESIS; TOXOPLASMOSIS; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; UNWANTED PREGNANCY; UTERINE ATONY; VIRUS LOAD; VIRUS TRANSMISSION; VOMITING; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; MATERNAL MORTALITY; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WORLD HEALTH ORGANIZATION; ZIDOVUDINE;

EID: 67650786470     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181a4f365     Document Type: Article

References (23)

1. UNAIDS. 2007 AIDS epidemic Update. 2007 Available at: http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en. pdf [Accessed on: July 2008].
2. Conner EM, Sperlin RS, Gelber R, et al. Reduction in maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173. (Pubitemid 24080219)
3. Samb B, Celetti F, Holloway J, et al. Rapid expansion of the health workforce in response to the HIV epidemic. N Engl J Med. 2007;357:2510-2514. (Pubitemid 350272794)
4. HIV/AIDS and work: global estimates, impact and response. Geneva. International Labour Office 2004. Available at: http:www.org/public/English/ protection/ trav/aids/activities/research-policy.htm [Accessed on: May 2008].
5. Shah IH, Say L. Maternal mortality maternity care from 1990 to 2005. Uneven but important gains. Reprod Health Matters. 2007;15:17-27.
6. Gray RH, Li X, KlgoziG, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366:1182-1188.
7. Moses A, Zmiba C, Kamanga E, et al. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIV NET 012 regimen in Malawi. AIDS. 2008;22:83-87. (Pubitemid 350294881)
8. Mseleku M, Smith T, Guidozzi F. HIV seropositive in pregnant South African woman who initially refuse routine antenatal HIV screening. Br J Obstet Gynaecol. 2005;112:370-371. (Pubitemid 40314018)
9. Mofenson LM. Antiretroviral treatment during pregnancy. In: Bartlett JG, Lockwood CJ, Up To Date 16.2 Desktop. Updated June 2008.
10. Tai J, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007;196: 1044-1052. (Pubitemid 47580299)
11. World Health Organization. Antiretroviral drugs for treating pregnant woman and preventing HIV infection in infants in resource-limited settings. Towards universal access. 2006. Available at: http://www.who.int/hiv/pub/ guidelines/ pmtct/en/index.html [Accessed on: July 2008].
12. United States Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1 -infected women for maternal health and interventions to reduce perinatal HIV-1 Transmission in the United States. Available at: http://www.hivatis.org [Accessed on: July 2008].
13. Walson JL, Brown E, Otieno P, et al. Morbidity among HIV infected mothers in Kenya: prevalence and correlates of illness during 2-year post partum follow up. J Acquir Immune Defic Syndr. 2007; 46:208-215. (Pubitemid 47482617)
14. Kamya MR, Gassira AF, Achan J, et al. Effects of trimethoprim- sulfamethoxazole and insecticide-treated bed nets on malaria among HIV-infected Ugandan children. AIDS. 2007;21:2059-2066. (Pubitemid 47462155)
15. Doherty T, Chopra M, Jackson D, et al. Effectiveness of the/WHO. UNICEF guidelines on infant feeding for HIV-positive woman: results from a prospective cohort study in South Africa. AIDS. 2007;21:1701-1797.
16. Coovadia HN, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV 1 during exclusive breastfeeding in the first 6 months of life: on intervention cohort study. Lancet. 2007;369:1107.
17. Palombi L, Macazzi MC, Voetberg A, et al. Treatment acceleration program experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS. 2007;21(suppl 4):565-571. (Pubitemid 47051751)
18. Mofenson LM. Antiretroviral prophylaxis to reduce breast milk transmission of HIV Type 1: new data but still questions. J Acquir Immune Defic Syndr. 2008;48:237-240.
19. Kumwenda NI, Hoover RD, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129.
20. Six Week Extended-dose Nevirapine (SWEN) Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomized controlled trials. Lancet. 2008;372:300-313.
21. UNICEF/WHO. Antenatal care in developing countries: promises, achievements and missed opportunities. Available at: http://www.who.int/ reproductive-health/publications/antenatal-care [Accessed on: June 2008].
22. WHO. Guidance on global scale up of the prevention of mother-to-child transmission of HIV: Towards universal access for women, infants and young children and eliminating HIV and AIDS among children. WHO 2007.
23. Read JS, Cahn P, Losso M, et al. Management of human deficiency virus-infected pregnant woman in Latin American and Caribbean Sites. Obstet Gynecol. 2007;109:1358-1367. (Pubitemid 46869875)